Optimizing Migraine Management: A Guide to Acute and Preventive Therapy

Optimizing Migraine Management: A Guide to Acute and Preventive Therapy

Activity type: Knowledge-based

Format: Live via webinar

Date: March 18, 2026 12:00-1:00pm via webinar

CPE Credit: 1.0 contact hour (0.1 CEU)

Target Audience: Pharmacists in any practice setting.

Why Attend: Updates to clinical guidelines for both acute and preventative migraine management were published in 2025 by the American College of Physicians. The use of CGRP receptor antagonists for management of migraines also continues to evolve. Despite the availability of evidence-based guidelines and an expanding range of treatment options, care gaps in migraine management remain, highlighting a need for targeted pharmacist education focused on appropriate therapy selection, patient counseling, and monitoring.

Objectives: 

1. Review acute and preventive migraine management options based on mechanism of action, clinical efficacy, safety considerations, and patient-specific factors.
2. Summarize current guideline recommendations for the selection and sequencing of acute and preventive migraine medications.
3. Discuss the role of pharmacists in patient making evidence-based recommendation, optimizing therapy, counseling patients, and monitoring to support treatment.

Program Schedule: 

12:00-12:05 pm: Introduction

12:05-12:50 pm: Educational presentation

12:50-1:00 pm: Q&A and learning assessment

Requirements for Obtaining Continuing Education Credit:

Learners must be present for 70% or more of the webinar. Please ensure your screen name accurately identifies you. The activity evaluation, which includes learning assessment questions, is a requirement for CPE credit to be awarded. There is no minimum passing score required for the learning assessment questions. It is strongly encouraged that all learners participate in the active learning components of the program to gain the full benefit of the educational activity.

Disclosure Declaration:

ACPE is committed to ensuring that accredited continuing education (1) presents learners with only accurate, balanced, and scientifically justified recommendations, and (2) protects learners from promotion, marketing, and commercial bias. The individuals involved with the planning and presentation of this activity have the following financial relationships to disclose:

All relevant financial relationships have been mitigated.

Financial Support: 

This program did not receive any external financial support.

Program Cost: 

Pharmacists and all other attendees: $25.00

Cancellation and Refund Policies:

Technical Requirements:

Please view CE21 technical requirements HERE

 

Accreditation Information: 

The University at Buffalo School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program has been accredited as a knowledge-based activity. Credit will be uploaded to the CPE Monitor to those who complete all components of the activity.  No partial credit will be awarded.  ACPE UAN 0044-0000-26-007-L01-P, 1.0 contact hour, 0.1 CEU

 

 

Webinar stock image attributed to: https://pixabay.com/photos/